SCHEMBL6422310

SCHEMBL6422310

CC(C)=C1Oc2cccc(OCCCCl)c2C1=O

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 3/20 0.36
STK17B O94768 2/20 0.35
KCNA3 P22001 1/20 0.35
PRKCA P17252 4/20 0.33
PNLIP P16233 1/20 0.32
MAOA P21397 1/20 0.32
MAOB P27338 1/20 0.32
LMNA P02545 2/20 0.31
SMN1; SMN2 Q16637 2/20 0.31
TXNRD1 Q16881 1/20 0.31
TXNRD3 Q86VQ6 1/20 0.31
TXNRD2 Q9NNW7 1/20 0.31
PTPN1 P18031 1/20 0.31
KDM4E B2RXH2 1/20 0.31
ALDH1A1 P00352 1/20 0.31
ELANE P08246 1/20 0.30
TP53 P04637 1/20 0.30
CYP1A2 P05177 1/20 0.30
CYP3A4 P08684 1/20 0.30
CYP2D6 P10635 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6426238 0.96 KCNA3 (0.37) MTNR1ASTK17BKCNA3PRKCAPNLIP
SCHEMBL6820565 0.87 KCNA3 (0.36) MTNR1ASTK17BKCNA3PRKCAPNLIP
SCHEMBL6823437 0.86 TSHR (0.41) MTNR1AKCNA3LMNAPTPN1ALDH1A1
SCHEMBL6824170 0.84 LMNA (0.47) MTNR1ASTK17BKCNA3PRKCALMNA
SCHEMBL6820552 0.84 STK17B (0.35) MTNR1ASTK17BKCNA3PRKCAPNLIP
SCHEMBL7347057 0.82 STK17B (0.33) STK17BTDP1
SCHEMBL7353733 0.82 MAOB (0.43) STK17BPRKCAMAOAMAOBLMNA
SCHEMBL6826208 0.82 F2RL3 (0.41) STK17BPRKCAPTPN1TDP1
SCHEMBL7347199 0.81 MAOB (0.33) STK17BPRKCAMAOAMAOBALDH1A1
SCHEMBL7346833 0.80 MAOB (0.37) STK17BPRKCAMAOAMAOBSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1012147-B1 O-SUBSTITUTED HYDROXYCUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC AGENTS HOFFMANN LA ROCHE (CH) 2005-11-02 EP disclosed
US-6200989-B1 ADMINISTERING AS UROKINASE PLASMINOGEN ACTIVATOR ANTAGONISTS, ANTITUMOR AND ANTIMETASTASIS AGENTS HOFFMANN-LA ROCHE INC. 2001-03-13 US disclosed
EP-1012147-A2 O-SUBSTITUTED HYDROXYCUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC AGENTS F. HOFFMANN-LA ROCHE AG (CH) 2000-06-28 EP disclosed
WO-1999006387-A2 O-SUBSTITUTED HYDROXYCUMARANONE DERIVATIVES AS ANTITUMOR AND ANTIMETASTATIC AGENTS F. HOFFMANN-LA ROCHE AG (CH) 1999-02-11 WO disclosed